Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5

Core Insights - Axsome Therapeutics, Inc. will report its financial results for Q2 2024 on August 5, 2024, before U.S. market opening, followed by a conference call at 8:00 a.m. Eastern Time to discuss results and provide a business update [1] Company Overview - Axsome Therapeutics, Inc. is focused on developing novel therapies for central nervous system (CNS) disorders with limited treatment options, aiming to transform treatment approaches through innovative mechanisms of action [2] Investor Relations - Investors can participate in the conference call by dialing (877) 405-1239, and a live webcast will be available on the company's website [1]